ARCHIVES

Frederick RFP Held Up; NCI Probably Will Reject Any Further Delay

This article is from The Cancer Letter archive.

Vol. 02 No. 42 | October 15, 1976

Download PDF Visit The Full Archive

Related Articles

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

A Conversation With Daniel Masys: Acronym “CABIG” Could Be Eliminated

January 6, 2012

CTRF Seeks Applications In Clinical Cancer Research.

January 28, 2000

Study: Nine Years After Diagnosis 9.3% of Survivors Still Smoke

August 29, 2014

FDA Proposes New Nonclinical Lab Regs

November 26, 1976

NCI Programs: Institute Funds 24 DNA Microarray Centers

September 24, 1999